Post-COVID-19 Syndrome
Infectious Disease·MeSH: Post-Acute COVID-19 Syndrome
Prevalence
10000.0 / 100K
Incidence
5000.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Post-COVID-19 Syndrome?
There are 1 clinical trial targeting Post-COVID-19 Syndrome tracked by BioSniper.
What is the prevalence of Post-COVID-19 Syndrome?
The estimated prevalence of Post-COVID-19 Syndrome is approximately 10000.0 per 100,000 population.
Deep-dive into Post-COVID-19 Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis